{"transactions":[{"id":1183594,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-04-02T16:26:00.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":false,"shares":46686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vested in full on March 31, 2025, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs vested in full on March 31, 2025, and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":46686},"source":{"system":"sec-edgar","filing":"0000905148-25-001048","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723751/000090514825001048/form4.xml","form_type":"4"}},{"id":1183593,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-04-02T16:26:00.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":true,"shares":46686,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":421705,"source":{"system":"sec-edgar","filing":"0000905148-25-001048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723751/000090514825001048/form4.xml","form_type":"4"}},{"id":1451813,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-07-18T16:24:01.000Z","date":"2024-07-16","kind":"exercise","planned":false,"acquired":false,"shares":26368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vested in full on July 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs vested in full on July 1, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":26368},"source":{"system":"sec-edgar","filing":"0000905148-24-001920","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723751/000090514824001920/form4.xml","form_type":"4"}},{"id":1451812,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-07-18T16:24:01.000Z","date":"2024-07-16","kind":"exercise","planned":false,"acquired":true,"shares":26368,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":375019,"source":{"system":"sec-edgar","filing":"0000905148-24-001920","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723751/000090514824001920/form4.xml","form_type":"4"}},{"id":1503746,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2024-05-23T19:15:32.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":37050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, this option will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."}],"balance_after":37050,"derivative":{"exercise_price":1.57,"expiration_date":"2034-05-20","underlying":"Common Stock","underlying_shares":37050},"source":{"system":"sec-edgar","filing":"0000905148-24-001617","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723751/000090514824001617/form4.xml","form_type":"4"}},{"id":1503745,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-05-23T19:15:32.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":46686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."}],"balance_after":46686,"derivative":{"underlying":"Common Stock","underlying_shares":46686},"source":{"system":"sec-edgar","filing":"0000905148-24-001617","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723751/000090514824001617/form4.xml","form_type":"4"}},{"id":1549797,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-04-03T16:36:05.000Z","date":"2024-04-01","kind":"exercise","planned":false,"acquired":false,"shares":134262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vested in full on March 31, 2024, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs vested in full on March 31, 2024, and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":134262},"source":{"system":"sec-edgar","filing":"0000905148-24-001076","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723751/000090514824001076/form4.xml","form_type":"4"}},{"id":1549796,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-03T16:36:05.000Z","date":"2024-04-01","kind":"exercise","planned":false,"acquired":true,"shares":134262,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":348651,"source":{"system":"sec-edgar","filing":"0000905148-24-001076","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723751/000090514824001076/form4.xml","form_type":"4"}},{"id":1692659,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-01-03T16:20:15.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":105389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."}],"balance_after":134262,"derivative":{"underlying":"Common Stock","underlying_shares":105389},"source":{"system":"sec-edgar","filing":"0000905148-24-000045","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723751/000090514824000045/form4.xml","form_type":"4"}},{"id":1813860,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-07T17:34:34.000Z","date":"2023-08-03","kind":"grant","planned":false,"acquired":true,"shares":12345,"price":1.62,"value":19998.9,"ownership":{"direct":true},"balance_after":214389,"source":{"system":"sec-edgar","filing":"0000905148-23-000630","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723751/000090514823000630/form4.xml","form_type":"4"}},{"id":1877454,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Restricted Stock Units","published_at":"2023-05-26T17:55:33.000Z","date":"2023-05-19","kind":"exercise","planned":false,"acquired":false,"shares":69619,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs. All of the RSUs shall vest on the first-year anniversary of the Date of Grant (the \"Vesting Date\"), unless Grantee leaves in good standing before 12 months, in which case they will vest pro-rata based on months served. This reporting person received a prorated amount of 69,619 RSUs, which is eleven of the twelve months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs. All of the RSUs shall vest on the first-year anniversary of the Date of Grant (the \"Vesting Date\"), unless Grantee leaves in good standing before 12 months, in which case they will vest pro-rata based on months served. This reporting person received a prorated amount of 69,619 RSUs, which is eleven of the twelve months."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs. All of the RSUs shall vest on the first-year anniversary of the Date of Grant (the \"Vesting Date\"), unless Grantee leaves in good standing before 12 months, in which case they will vest pro-rata based on months served. This reporting person received a prorated amount of 69,619 RSUs, which is eleven of the twelve months."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":69619},"source":{"system":"sec-edgar","filing":"0001628280-23-019989","document":"wk-form4_1685138119.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023019989/wk-form4_1685138119.xml","form_type":"4"}},{"id":1877453,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-26T17:55:33.000Z","date":"2023-05-19","kind":"exercise","planned":false,"acquired":true,"shares":69619,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs. All of the RSUs shall vest on the first-year anniversary of the Date of Grant (the \"Vesting Date\"), unless Grantee leaves in good standing before 12 months, in which case they will vest pro-rata based on months served. This reporting person received a prorated amount of 69,619 RSUs, which is eleven of the twelve months."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs. All of the RSUs shall vest on the first-year anniversary of the Date of Grant (the \"Vesting Date\"), unless Grantee leaves in good standing before 12 months, in which case they will vest pro-rata based on months served. This reporting person received a prorated amount of 69,619 RSUs, which is eleven of the twelve months."}],"balance_after":69619,"source":{"system":"sec-edgar","filing":"0001628280-23-019989","document":"wk-form4_1685138119.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023019989/wk-form4_1685138119.xml","form_type":"4"}},{"id":1878194,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-05-25T18:21:41.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":28873,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F3","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."}],"balance_after":28873,"derivative":{"underlying":"Common Stock","underlying_shares":28873},"source":{"system":"sec-edgar","filing":"0001140361-23-026716","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723751/000114036123026716/form4.xml","form_type":"4"}},{"id":1928438,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-04-04T16:33:47.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":false,"shares":150711,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vested in full on March 31, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs vested in full on March 31, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":150711},"source":{"system":"sec-edgar","filing":"0001140361-23-016257","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723751/000114036123016257/form4.xml","form_type":"4"}},{"id":1928437,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-04-04T16:33:47.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":true,"shares":150711,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":202044,"source":{"system":"sec-edgar","filing":"0001140361-23-016257","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723751/000114036123016257/form4.xml","form_type":"4"}},{"id":2062864,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-01-05T16:31:17.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":4878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."}],"balance_after":150711,"derivative":{"underlying":"Common Stock","underlying_shares":4878},"source":{"system":"sec-edgar","filing":"0001140361-23-000670","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723751/000114036123000670/form4.xml","form_type":"4"}},{"id":2068014,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-01-04T18:20:10.000Z","date":"2023-01-01","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."}],"balance_after":145833,"derivative":{"underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001140361-23-000516","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723751/000114036123000516/form4.xml","form_type":"4"}},{"id":2108672,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-11-21T18:03:14.000Z","date":"2022-11-21","kind":"purchase","acquired":true,"shares":43478,"price":1.15,"value":49999.7,"ownership":{"direct":true},"balance_after":51333,"source":{"system":"sec-edgar","filing":"0001140361-22-042603","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723751/000114036122042603/form4.xml","form_type":"4"}},{"id":2248654,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Restricted Stock Units","published_at":"2022-06-02T16:23:37.000Z","date":"2022-05-31","kind":"grant","acquired":true,"shares":75949,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in full on May 31, 2022. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."}],"balance_after":75949,"derivative":{"underlying":"Common Stock","underlying_shares":75949},"source":{"system":"sec-edgar","filing":"0001628280-22-016066","document":"wf-form4_165420140098959.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828022016066/wf-form4_165420140098959.xml","form_type":"4"}},{"id":2255342,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2022-05-26T16:16:21.000Z","date":"2022-05-24","kind":"grant","acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock and has no expiration date."},{"field":"shares","element":"transactionShares","label":"F3","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."}],"balance_after":83333,"derivative":{"underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001140361-22-020789","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723751/000114036122020789/form4.xml","form_type":"4"}},{"id":2461108,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-22T16:42:07.000Z","date":"2021-12-20","kind":"purchase","acquired":true,"shares":5855,"price":4.2924,"value":25132.002,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares of Common Stock were purchased in multiple transactions at prices ranging from $4.27 to $4.33, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":7855,"source":{"system":"sec-edgar","filing":"0001567619-21-022443","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723751/000156761921022443/doc1.xml","form_type":"4"}},{"id":2647799,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true}}],"security":"Stock Options (Right to buy)","published_at":"2021-07-01T18:24:21.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":34385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on March 31, 2022."}],"balance_after":34385,"derivative":{"exercise_price":13.72,"expiration_date":"2031-06-28","underlying":"Common Stock","underlying_shares":34385},"source":{"system":"sec-edgar","filing":"0000905148-21-000539","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723751/000090514821000539/form4.xml","form_type":"4"}},{"id":2699989,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-24T21:59:38.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":35168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on May 20, 2022."}],"balance_after":35168,"derivative":{"exercise_price":7.68,"expiration_date":"2031-05-20","underlying":"Common Stock","underlying_shares":35168},"source":{"system":"sec-edgar","filing":"0001104659-21-071499","document":"tm2117458-8_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465921071499/tm2117458-8_4.xml","form_type":"4"}},{"id":2994906,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-03T18:14:04.000Z","date":"2020-10-30","kind":"purchase","acquired":true,"shares":2000,"price":18,"value":36000.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001209191-20-056736","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723751/000120919120056736/doc4.xml","form_type":"4"}},{"id":3185365,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-04-03T12:22:29.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":13779,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments, with the first installment vesting on May 1, 2020."}],"balance_after":13779,"derivative":{"exercise_price":8.33,"expiration_date":"2030-04-01","underlying":"Common Stock","underlying_shares":13779},"source":{"system":"sec-edgar","filing":"0001628280-20-004575","document":"wf-form4_158593093251932.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828020004575/wf-form4_158593093251932.xml","form_type":"4"}},{"id":3193815,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-03-27T21:09:02.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":12290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Form 4 was inadvertently not filed within the required time following the transaction date of April 1, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in twelve equal monthly installments, with the first installment vesting on May 1, 2019."}],"balance_after":12290,"derivative":{"exercise_price":21.02,"expiration_date":"2029-04-01","underlying":"Common Stock","underlying_shares":12290},"source":{"system":"sec-edgar","filing":"0001628280-20-004267","document":"wf-form4_158535772231600.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828020004267/wf-form4_158535772231600.xml","form_type":"4"}},{"id":3975467,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-04-03T15:14:22.000Z","date":"2018-04-01","kind":"grant","acquired":true,"shares":9476,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments, with the first installment vesting on May 1, 2018."}],"balance_after":9476,"derivative":{"exercise_price":22.85,"expiration_date":"2028-04-01","underlying":"Common Stock","underlying_shares":9476},"source":{"system":"sec-edgar","filing":"0001144204-18-018914","document":"tv490264_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000114420418018914/tv490264_4.xml","form_type":"4"}},{"id":4150498,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-11-28T21:22:02.000Z","date":"2017-11-14","kind":"grant","acquired":true,"shares":29765,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 5 equal annual installments, with the first installment vesting on November 14, 2018."}],"balance_after":29765,"derivative":{"exercise_price":19.15,"expiration_date":"2027-11-14","underlying":"Common Stock","underlying_shares":29765},"source":{"system":"sec-edgar","filing":"0001144204-17-061253","document":"tv480318_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/727207/000114420417061253/tv480318_4.xml","form_type":"4"}},{"id":4150497,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":81246,"kind":"person","name":"Watts Charles M","position":1,"cik":"0001723751","reported_name":"Watts Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-11-28T21:22:02.000Z","date":"2017-11-14","kind":"grant","acquired":true,"shares":3887,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 5 equal monthly installments, with the first installment vesting on December 14, 2017."}],"balance_after":3887,"derivative":{"exercise_price":19.15,"expiration_date":"2027-11-14","underlying":"Common Stock","underlying_shares":3887},"source":{"system":"sec-edgar","filing":"0001144204-17-061253","document":"tv480318_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000114420417061253/tv480318_4.xml","form_type":"4"}}]}